LXRX   $1.655  -2.36% Market Closed After Close 1.66 0.30%

Lexicon Pharmaceuticals Inc
Total Cash 309.96M
totalCashPerShare 0.857
EBITDA -196.47M
Total Debt 105.68M
quickRatio 11.213
currentRatio 11.51
Total Revenue 3.64M
debtToEquity 44.035
Revenue/Share 0.014
ROA -0.35694
ROE -0.9481
grossProfits
freeCashflow -116.79M
operatingCashflow -195.84M
earningsGrowth
revenueGrowth 4.196
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -33.60899
profitMargins 0.0
enterpriseValue 410.25M
forwardPE -2.9824562
floatShares 182.14M
sharesOutstanding 361.49M
sharesShort 25.39M
sharesShortPriorMonth 22.35M
dateShortInterest
sharesPercentSharesOut 0.07%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.79%
Short Ratio help_outline 8.36%
shortPercentOfFloat 0.16%
impliedSharesOutstanding
bookValue 0.664
Price To Book help_outline 2.56
earningsQuarterlyGrowth
netIncomeToCommon -202.11M
trailingEps -0.78%
forwardEps -0.57%
enterpriseToEbitda -2.09
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.16 3Q 2024
institutionsCount 172
lastUpdated Sept. 16, 2024, 12:32 p.m.